Dr. Michael X. Repka

Courtney L. Kraus, M.D., is Knights Templar Eye Foundation Professor of Ophthalmology at the Wilmer Eye Institute, Johns Hopkins Medicine. Dr. Kraus specializes in pediatric ophthalmology and adult strabismus, including amblyopia (lazy eye), with a particular interest in pediatric cataract and corneal diseases. She has enjoyed participating in surgical mission trips to underserved areas in the developing world. Dr. Kraus received her medical degree from Washington University in St. Louis, Missouri, where she also completed her residency in ophthalmology after an internship in internal medicine at St. John’s Mercy Medical Center in Creve Coeur, Missouri. She then completed a fellowship in pediatric ophthalmology and adult strabismus at the Storm Eye Institute at The Medical University of South Carolina. Dr. Kraus is rated as a Distinguished provider by MediFind in the treatment of Glaucoma. Her top areas of expertise are Strabismus, Idiopathic Short Stature (ISS), Brown Syndrome, Vitrectomy, and Cataract Removal.

Tadele Jembere is an Ophthalmologist and a Pediatrics provider in Washington, Washington, D.c.. Dr. Jembere is rated as an Advanced provider by MediFind in the treatment of Glaucoma. His top areas of expertise are Astigmatism, Presbyopia, Glaucoma, and Cataract.

Jefferson Doyle, M.D., Ph.D., M.H.S. specializes in pediatric ophthalmology and genetic eye diseases and is the recipient of the 2023 Andreas C. Dracopoulos & Daniel Finkelstein, M.D. Rising Professorship in Ophthalmology. His main focus is pediatric and juvenile forms of cataracts, glaucoma, anterior segment dysgenesis, and ectopia lentis. His genetics interests include Marfan syndrome and related connective tissue disorders, complex inherited forms of strabismus in both children and adults (e.g. CFEOM, Duane syndrome), and pediatric retinal dystrophies. Dr. Doyle has published extensively on a number of genetic disorders over the past decade, holds several patents for novel therapeutic approaches to treat them, and has given many national and international talks about them. Dr. Doyle's main research focus is understanding the genetic causes and molecular mechanisms driving genetic diseases, and utilizing that knowledge to develop new therapeutic strategies for them. Over the past decade, he has played a significant role in advancing our understanding of Marfan syndrome and related connective tissue disorders. His work and that of collaborators has led to the discovery of the genetic causes of Shprintzen-Goldberg syndrome and Loeys-Dietz like syndrome. His work has also led to a much better understanding of the molecular mechanisms driving Marfan syndrome, and he holds two patents for novel therapeutic strategies to treat it. Part of his current work focuses on the identification of genes that protect people from developing a number of genetic disorders, and leveraging that knowledge to develop new therapies for those diseases. He also has an interest in pediatric myopia, and has ongoing pre-clinical studies seeking to understand the mechanisms that may drive it and the development of novel therapeutic strategies to treat it. Recent News Articles and Media Coverage A Center for Genetic Eye Disease, Wilmer Insider (Oct. 2021). Dr. Doyle is rated as an Advanced provider by MediFind in the treatment of Glaucoma. His top areas of expertise are Duane-Radial Ray Syndrome, Ehlers-Danlos Syndrome (EDS), Vascular Ehlers-Danlos Syndrome (VEDS), and Strabismus.